C.F.R. » Title 21 » CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES › SUBCHAPTER D—DRUGS FOR HUMAN USE › PART 358—MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE › Subpart G—Pediculicide Drug Products

21 C.F.R. § 358.610

Pediculicide active ingredients

Read at: eCFRecfr.gov CornellLII GovInfogovinfo.gov CasesGoogle Scholar

The active ingredients of the product consist of the combination of pyrethrum extract (providing a concentration of pyrethrins of 0.17 to 0.33 percent) with piperonyl butoxide (2 to 4 percent) in a nonaerosol dosage formulation.

[63 FR 43303, Aug. 13, 1998]
Notes of Decisions
Cited in 2 cases, 2003–2003 · leading case: Warner-Lambert Co. v. Mills, 117 S.W.3d 488 (Tex. App. 2003).
Sort: Relevance Newest Treatment
Warner-Lambert Co. v. Mills, 117 S.W.3d 488 (Tex. App. 2003). · cites it 2× “…pyrethrins of 0.17 to 0.33 percent) with piperonyl butoxide (2 to 4 percent) in a nonaerosol dosage formulation." See 21 C.F.R. § 358.610 .”
Warner-Lambert Co., Pfizer, Inc., Bayer Corp., Del Pharm., Inc., Del Labs., Inc. & Care Tech., Inc. v. Katherine Mills & Veronica Evans, Individually & on Behalf of All Others Similarly Situated (Tex. App. 2003). “…pyrethrins of 0.17 to 0.33 percent) with piperonyl butoxide (2 to 4 percent) in a nonaerosol dosage formulation." See 21 C.F.R. § 358.610 .”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.